FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

B Calandra

Research Profile

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Paul R Gouldson; B Calandra; P Legoux; A Kernéis; Murielle Rinaldi-Carmona; Francis Barth; Gérard Le-Fur; Pascual Ferrara; David Shire
Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.
B Calandra; M Portier; A Kernéis; M Delpech; C Carillon; Gérard Le-Fur; Pascual Ferrara; David Shire
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
M Portier; Murielle Rinaldi-Carmona; F Pecceu; Thérèse Combes; C Poinot-Chazel; B Calandra; Francis Barth; Gérard Le-Fur; Pierre Casellas
SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of B Calandra (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Paul R Gouldson; B Calandra; P Legoux; A Kernéis; Murielle Rinaldi-Carmona; Francis Barth; Gérard Le-Fur; Pascual Ferrara; David Shire
Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.
European journal of pharmacology 2000;401(1):17-25.
1999: B Calandra; M Portier; A Kernéis; M Delpech; C Carillon; Gérard Le-Fur; Pascual Ferrara; David Shire
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
European journal of pharmacology 1999;374(3):445-55.
1999: M Portier; Murielle Rinaldi-Carmona; F Pecceu; Thérèse Combes; C Poinot-Chazel; B Calandra; Francis Barth; Gérard Le-Fur; Pierre Casellas
SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.
The Journal of pharmacology and experimental therapeutics 1999;288(2):582-9.
1999: David Shire; B Calandra; Monsif Bouaboula; Francis Barth; Murielle Rinaldi-Carmona; Pierre Casellas; Pascual Ferrara
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.
Life sciences 1999;65(6-7):627-35.
1998: Murielle Rinaldi-Carmona; Francis Barth; J Millan; Jean-Marie Derocq; Pierre Casellas; C Congy; Didier Oustric; M Sarran; Monsif Bouaboula; B Calandra; M Portier; David Shire; J C Brelière; Gérard Le-Fur
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
The Journal of pharmacology and experimental therapeutics 1998;284(2):644-50.
1997: Monsif Bouaboula; S Perrachon; L Milligan; X Canat; Murielle Rinaldi-Carmona; M Portier; Francis Barth; B Calandra; F Pecceu; J Lupker; Jean-Pierre Maffrand; Gérard Le-Fur; Pierre Casellas
A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.
The Journal of biological chemistry 1997;272(35):22330-9.
1996: Murielle Rinaldi-Carmona; B Calandra; David Shire; Monsif Bouaboula; D Oustric; Francis Barth; Pierre Casellas; Pascual Ferrara; Gérard Le-Fur
Characterization of two cloned human CB1 cannabinoid receptor isoforms.
The Journal of pharmacology and experimental therapeutics 1996;278(2):871-8.
1996: David Shire; B Calandra; Murielle Rinaldi-Carmona; D Oustric; B Pessègue; O Bonnin-Cabanne; Gérard Le-Fur; Daniel Caput; Pascual Ferrara
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.
Biochimica et biophysica acta 1996;1307(2):132-6.
1996: Monsif Bouaboula; C Poinot-Chazel; Jean Marchand; X Canat; Bernard Bourrié; Murielle Rinaldi-Carmona; B Calandra; Gérard Le-Fur; Pierre Casellas
Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.
European journal of biochemistry / FEBS 1996;237(3):704-11.
1996: David Shire; B Calandra; M Delpech; X Dumont; Mourad Kaghad; Gérard Le-Fur; Daniel Caput; Pascual Ferrara
Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.
The Journal of biological chemistry 1996;271(12):6941-6.
1995: Monsif Bouaboula; C Poinot-Chazel; Bernard Bourrié; X Canat; B Calandra; Murielle Rinaldi-Carmona; Gérard Le-Fur; Pierre Casellas
Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
The Biochemical journal 1995;312 ( Pt 2)():637-41.
1995: David Shire; C Carillon; Mourad Kaghad; B Calandra; Murielle Rinaldi-Carmona; Gérard Le-Fur; Daniel Caput; Pascual Ferrara
An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing.
The Journal of biological chemistry 1995;270(8):3726-31.
1994: Murielle Rinaldi-Carmona; Francis Barth; M Héaulme; David Shire; B Calandra; C Congy; S Martinez; J Maruani; G Néliat; Daniel Caput
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
FEBS letters 1994;350(2-3):240-4.